This pharmaceutical company specializes in oncology and has nearly two decades of experience developing generic and specialty drugs. They focus on delivering affordable, world-class chemotherapy medications across a wide range of therapeutic areas. Their robust research and development team possesses expertise in complex drug molecule development, serving diverse markets globally. With over 35 developed generics and specialty drugs, they have filed over 40 dossiers across 25 countries in emerging markets. The company is committed to expanding its presence in the oncology therapeutic area within emerging markets.

This CTD dossier owner and manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

This specialty biopharmaceutical company focuses on oncology and critical care medications, offering a diverse portfolio of over 650 product registrations across regions including the EU, North America, and Asia. Their expertise includes developing innovative, cost-effective drug delivery systems like microspheres, liposomes, and nanoparticles. They are recognized for manufacturing high-quality products adhering to global standards such as WHO-GMP and Schedule M certifications. Key therapy areas include oncology (with a focus on oral medications) and critical care, encompassing cardiovascular and anesthesia segments. The company has launched several first-in-market products and continues to expand its presence globally.